Literature DB >> 15249324

Relative risk of knee chondrocalcinosis in siblings of index cases with pyrophosphate arthropathy.

W Zhang1, R Neame, S Doherty, M Doherty.   

Abstract

OBJECTIVES: To examine the genetic contribution to common, apparently sporadic, radiographic knee chondrocalcinosis (CC) and pyrophosphate arthropathy (PA).
METHOD: (1).
DESIGN: radiographic sibling study. Comparison of the prevalences of knee CC and PA in siblings of index cases with PA with those in the community. (2).
SUBJECTS: 80 index cases with PA listed for total knee replacement; 122 of their siblings aged >or=40 years; and 1729 participants from community knee pain surveys who had undergone knee radiographs. (3). MAIN OUTCOME MEASURE: odds ratios of knee CC and PA in siblings versus community participants.
RESULTS: The prevalence of knee CC was 13% (15/116) in the siblings and 6.9% (119/1727) in the community participants. The adjusted odds ratio (aOR) was 1.2, 95% confidence interval (CI) 0.6 to 2.3. The main risk factors for knee CC were age, knee pain, and knee OA. The prevalence of knee PA was 7% (9/122) in the siblings and 3.4% (59/1729) among the community participants (aOR = 1.1, 95% CI 0.4 to 2.7). The main risk factors for PA were age and knee pain. The age, sex, and knee pain standardised prevalence of PA in the Nottingham community aged >or=40 was 2.40%.
CONCLUSION: The risk of knee CC and PA in siblings of index cases with PA is no higher than that in the general population. Although rare familial CC is recognised, this study suggests that no major genetic predisposition to CC occurs in common symptomatic knee OA.

Entities:  

Mesh:

Year:  2004        PMID: 15249324      PMCID: PMC1755084          DOI: 10.1136/ard.2003.015206

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

1.  Chondrocalcinosis articularis Section L Clinical and radiological study.

Authors:  D ZITNAN; S SIT'AJ
Journal:  Ann Rheum Dis       Date:  1963-05       Impact factor: 19.103

2.  Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease.

Authors:  Charlene J Williams; Adrian Pendleton; Gina Bonavita; Antonio J Reginato; Anne E Hughes; Shelly Peariso; Michael Doherty; Daniel J McCarty; Lawrence M Ryan
Journal:  Arthritis Rheum       Date:  2003-09

3.  Mutations in ANKH cause chondrocalcinosis.

Authors:  Adrian Pendleton; Michelle D Johnson; Anne Hughes; Kyle A Gurley; Andrew M Ho; Michael Doherty; Josh Dixey; Pierre Gillet; Damien Loeuille; Rodney McGrath; Antonio Reginato; Rita Shiang; Gary Wright; Patrick Netter; Charlene Williams; David M Kingsley
Journal:  Am J Hum Genet       Date:  2002-09-20       Impact factor: 11.025

4.  Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.

Authors:  Charlene J Williams; Yun Zhang; Andrew Timms; Gina Bonavita; Francisco Caeiro; John Broxholme; Jonathan Cuthbertson; Yvonne Jones; Raul Marchegiani; Antonio Reginato; R Graham G Russell; B Paul Wordsworth; Andrew J Carr; Matthew A Brown
Journal:  Am J Hum Genet       Date:  2002-09-17       Impact factor: 11.025

5.  Role of the mouse ank gene in control of tissue calcification and arthritis.

Authors:  A M Ho; M D Johnson; D M Kingsley
Journal:  Science       Date:  2000-07-14       Impact factor: 47.728

6.  Development of a logically devised line drawing atlas for grading of knee osteoarthritis.

Authors:  Y Nagaosa; M Mateus; B Hassan; P Lanyon; M Doherty
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

7.  Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial.

Authors:  K S Thomas; K R Muir; M Doherty; A C Jones; S C O'Reilly; E J Bassey
Journal:  BMJ       Date:  2002-10-05

8.  UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte.

Authors:  R L Neame; A J Carr; K Muir; M Doherty
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

9.  Clinical, radiographic and pathologic abnormalities in calcium pyrophosphate dihydrate deposition disease (CPPD): pseudogout.

Authors:  D Resnick; G Niwayama; T G Goergen; P D Utsinger; R F Shapiro; D H Haselwood; K B Wiesner
Journal:  Radiology       Date:  1977-01       Impact factor: 11.105

Review 10.  Roentgenographic aspects of calcium pyrophosphate dihydrate crystal deposition disease (pseudogout).

Authors:  H K Genant
Journal:  Arthritis Rheum       Date:  1976 May-Jun
View more
  6 in total

1.  Risk factors for pseudogout in the general population.

Authors:  Young Hee Rho; Yanyan Zhu; Yuqing Zhang; Anthony M Reginato; Hyon K Choi
Journal:  Rheumatology (Oxford)       Date:  2012-08-11       Impact factor: 7.580

Review 2.  Pathophysiology of articular chondrocalcinosis--role of ANKH.

Authors:  Abhishek Abhishek; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2010-11-23       Impact factor: 20.543

Review 3.  Genetic factors in the pathogenesis of CPPD crystal deposition disease.

Authors:  Ana Rita Couto; Matthew A Brown
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

4.  Acute CPP Crystal Arthritis Causing Carpal Tunnel Syndrome.

Authors:  Masahiro Yamamura
Journal:  Intern Med       Date:  2018-05-18       Impact factor: 1.271

5.  Prevalence and incidence of non-gout crystal arthropathy in southern Sweden.

Authors:  Mohaned Hameed; Aleksandra Turkiewicz; Martin Englund; Lennart Jacobsson; Meliha C Kapetanovic
Journal:  Arthritis Res Ther       Date:  2019-12-17       Impact factor: 5.156

6.  The association between ANKH promoter polymorphism and chondrocalcinosis is independent of age and osteoarthritis: results of a case-control study.

Authors:  Abhishek Abhishek; Sally Doherty; Rose Maciewicz; Kenneth Muir; Weiya Zhang; Michael Doherty; Anna M Valdes
Journal:  Arthritis Res Ther       Date:  2014-01-27       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.